Eagle Meds Services
NovoLog (insulin aspart) product image
Available to sourceHuman Prescription DrugDiabetes & Endocrine

Xultophy 100/3.6 (insulin degludec and liraglutide)

100 [iU]/mL / 3.6 mg/mL · Injection Solution
By Novo Nordisk
NDC
0169-2911
Route
Subcutaneous
Therapeutic class
GLP-1 Receptor Agonist , Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog , Insulin [CS]
Marketing category
BLA

Package sizes

  • 5 SYRINGE, PLASTIC in 1 CARTON (0169-2911-15) / 3 mL in 1 SYRINGE, PLASTICNDC 0169-2911-15Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Xultophy 100/3.6 (insulin degludec and liraglutide)
NDC 0169-2911